The latest data from GuruFocus shows that EVP, Corp Strategy & Develop Joseph Laplume sold 534 shares of Charles River Laboratories International Inc (CRL) on 2022-11-04.
Investors may be concerned when an insider sells shares. It could be a sign that insiders are turning bearish on the stock of their own company. Insiders have a unique advantage in determining the value of their company, so when they begin selling, investors pay attention. Let’s take a look at this insider sell to see if Charles River Laboratories International Inc deserves some skepticism from investors.
Joseph Laplume’s trades
Over the past year, Joseph Laplume has sold 2668 shares in total.
This means that Joseph Laplume has been selling their company’s stock over a longer term. This could actually be a positive sign for the stock, contrary to expectations. When insiders sell frequently, it could be because their company issues a lot of stock options to pay executives. The executives will then sell some of the new shares for cash. Of course, it is also possible that the selling was due to insiders becoming more bearish on the stock. Investors should be cautious when evaluating insider selling.
Even if one insider is selling, that doesn’t mean that other insiders are bearish on the stock. Are other insiders selling the stock as well, or have the company’s top executives and owners been doing more buying recently?
The insider transaction history for Charles River Laboratories International Inc shows than there have been 0 insiders buys in total over the past year. Meanwhile, there have been 8 insider sells over the same timeframe.
Joseph Laplume is not the only insider that has been selling shares recently; other company insiders are doing more selling than buying as well, which could be worrying for investors. However, we should keep in mind that insiders sell for many reasons, such as needing the cash or taking advantage of the company’s stock buyback plans. High insider selling could be a bad sign or a neutral sign, depending on the reasoning behind the sales.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.